Cell of origin determines clinically relevant subtypes of MLL-rearranged AML

Overview of attention for article published in Leukemia, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users
patent: 5 patents

facebook: 1 Facebook page
bluesky: 1 Bluesky user

Readers on

mendeley: 226 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 5,098 followers.

Previous efforts across different fields to study the cancer cell‐of‐origin model, have suggested that the type of cell acquiring driver mutations is very important and dictates tumor behavior. https://t.co/El0gzaVhcg https://t.co/cQKZwNHRUv https://t.co…

Cell of origin determines clinically relevant subtypes of MLL-rearranged #AML http://t.co/FtDMnRhc #leukemia

Vegetable compound could become ingredient to treating #leukemia http://t.co/uqKiQe1F

#Cell of Origin Determines Clinically Relevant Subtypes of MLL-Rearranged #AML http://t.co/EOi5BghV

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.